ALFA Filings
Every announcement, straight from the exchange
Every Tatva Chintan Pharma Chem other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
The company has filed its quarterly shareholding pattern as per SEBI regulations. This routine disclosure provides details on the current shareholding structure.
Tatva Chintan Pharma Chem Limited is communicating the process for TDS on the final dividend for FY 2025-26 to its shareholders. Shareholders are required to submit necessary tax declarations by 10 September 2026.
Tatva Chintan Pharma Chem Limited submitted its Annual Secretarial Compliance Report for FY26. The auditor confirmed total compliance with SEBI listing regulations and guidelines.
Tatva Chintan Pharma Chem Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The certificate from MUFG Intime India confirms that security certificates received for dematerialisation were processed and cancelled within prescribed timelines.